[HTML][HTML] Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy

EE Babes, C Bustea, T Behl, MM Abdel-Daim… - Biomedicine & …, 2022 - Elsevier
Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …

[HTML][HTML] Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases

S Barungi, P Hernández-Camarero… - Frontiers in Cell and …, 2023 - frontiersin.org
Cardiovascular diseases (CVD) are the leading causes of death and disability in the world.
Among all CVD, the most common is coronary artery disease (CAD). CAD results from the …

[HTML][HTML] Long term outcomes of percutaneous coronary intervention vs coronary artery bypass grafting in patients with diabetes mellitus with multi vessels diseases: A …

V Jaiswal, Y Sattar, SP Ang, A Ishak, S Naz… - IJC Heart & …, 2023 - Elsevier
Aims Long term cardiovascular outcome comparison of multivessel coronary disease among
patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI) or …

[HTML][HTML] Impact of Advanced Age on the incidence of major adverse Cardiovascular events in patients with type 2 diabetes Mellitus and stable coronary artery disease …

C González-Juanatey, M Anguita-Sánchez… - Journal of Clinical …, 2023 - mdpi.com
Patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) without
myocardial infarction (MI) or stroke are at high risk for major cardiovascular events (MACEs) …

A Prospective Study on Activities of Daily Living, Comfort, Body Image, and Cardiac Symptoms in Coronary Artery Bypass Patients

İ Dolu, H Demirtaş, S Çelik - Pain Management Nursing, 2024 - Elsevier
Background A coronary artery bypass graft procedure reduces mortality for cardiovascular
patients, but those undergoing it often face negative body perception, loss of daily activities …

Effect of glucagon-like peptide-1 receptor agonists administration during coronary artery bypass grafting: a systematic review and meta-analysis of randomized control …

AR Watkins, N Fialka, R El-Andari, JJH Kang… - Future …, 2023 - Taylor & Francis
Plain Language Summary Aim: To determine if glucagon-like peptide-1 receptor agonists
(GLP-1 RAs) can benefit patients receiving coronary artery bypass graft (CABG), GLP-1 RAs …

[HTML][HTML] The Extents of Coronary Heart Disease and the Severity of Newly Developed Dry Eye Disease: A Nationwide Cohort Study

CY Lee, SF Yang, JY Huang, CK Chang - Diagnostics, 2024 - mdpi.com
This study aimed to evaluate the potential association between coronary heart disease
(CHD) severity and the subsequent dry eye disease (DED) with a different severity through …

[HTML][HTML] Reassessing Revascularization Strategies in Coronary Artery Disease and Type 2 Diabetes Mellitus

B Liang, X He, N Gu - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is still
controversial in patients with coronary artery disease (CAD) and type 2 diabetes mellitus …

[PDF][PDF] CABG 和PCI 治疗冠心病并发糖尿病患者的长期预后观察

何柱辉, 黄国强, 韩永继 - 临床心血管病杂志, 2023 - lcxxgen.whuhzzs.com
CABG和PCI治疗冠心病并发糖尿病患者的长期预后观察 Page 1 2023,39 临床心血管病杂志 (11):887-889
JClinCardiol(China) 引用本文:何柱辉,黄国强,韩永继.CABG 和PCI治疗冠心病并发糖尿病患者 …

[HTML][HTML] Реваскуляризация коронарных и периферических артерий при сахарном диабете: взгляд кардиолога

СГ Канорский, МН Мамедов - Международный журнал сердца и …, 2021 - cyberleninka.ru
Сахарный диабет (СД) является важным фактором риска инфаркта миокарда,
инсульта, ампутации нижних конечностей, что связано с ускоренным поражением …